Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

InspireMD (NSPR) Return on Sales (2016 - 2025)

InspireMD filings provide 16 years of Return on Sales readings, the most recent being 0.09% for Q4 2025.

  • On a quarterly basis, Return on Sales changed 0.0% to 0.09% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 0.0% change, with the full-year FY2025 number at 0.05%, down 1.0% from a year prior.
  • Return on Sales hit 0.09% in Q4 2025 for InspireMD, up from 0.05% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.09% in Q4 2024 to a low of 0.07% in Q1 2025.
  • Median Return on Sales over the past 5 years was 0.04% (2023), compared with a mean of 0.03%.
  • Biggest five-year swings in Return on Sales: rose 21bps in 2021 and later decreased -3bps in 2025.
  • InspireMD's Return on Sales stood at 0.03% in 2021, then tumbled by -60bps to 0.05% in 2022, then increased by 30bps to 0.03% in 2023, then skyrocketed by 371bps to 0.09% in 2024, then dropped by -3bps to 0.09% in 2025.
  • The last three reported values for Return on Sales were 0.09% (Q4 2025), 0.05% (Q3 2025), and 0.07% (Q2 2025) per Business Quant data.